Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47.6M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
23.1M
-
Shares change
-
+2.22M
-
Total reported value, excl. options
-
$274M
-
Value change
-
+$29M
-
Number of buys
-
18
-
Number of sells
-
-11
-
Price
-
$11.93
Significant Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q4 2020
40 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares, no par value per share as of Q4 2020.
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.1M shares
of 47.6M outstanding shares and own 48.57% of the company stock.
Largest 10 shareholders include BVF INC/IL (3.71M shares), Blackstone Group Inc. (3.57M shares), Avidity Partners Management LP (2.56M shares), Soleus Capital Management, L.P. (2.38M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.34M shares), Vivo Capital, LLC (1.89M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1.05M shares), Omega Fund Management, LLC (706K shares), Logos Global Management LP (550K shares), and JANUS HENDERSON GROUP PLC (509K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.